Scrip
Market Insight - Cost of capital in royalty monetisation transactions
25 August 2009
Dr Ken Macleod, John Leone and Dr Walter Flamenbaum
25 August 2009
Dr Ken Macleod, John Leone and Dr Walter Flamenbaum
In the current climate it is unsurprising that biopharmaceutical companies are tapping alternative sources of financing, including royalty monetisation for commercial products.
Dr Ken Macleod
,
John Leone
and
Dr Walter Flamenbaum
explain how investors weigh...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
